A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...

A mother of three was blindsided by a cervical cancer diagnosis just days before her 30th birthday — despite experiencing ...

A new report explores the disproportionately high death rate among Black women in the Delta from cervical cancer.

Here are 5 important questions to ask if you’ve been told you have cervical dysplasia: ...

“Our findings demonstrate that the therapeutic vaccine Vvax001 is safe, well-tolerated, and effective in eradicating HPV16-associated CIN3 lesions and clearing the underlying persistent HPV16 ...

Getting the HPV vaccine in early adolescence may lower the risk of HPV-related cancers before exposure occurs. Learn about ...

Dr. M.G. Janaki, Consultant Radiation Oncologist at Ramaiah Memorial Hospital, shares her expertise on cervical cancer, its ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.

An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive cervical intraepithelial neoplasia grade 3 (CIN3), according to results from ...

Cervical cancer, the fourth most common cancer in women, is closely linked to persistent HPV infections. Early detection through Pap smears and HPV testing can significantly reduce mortality.

In conjunction with Cervical Cancer Awareness Month, it is crucial to highlight the introduction of the Human Papillomavirus (HPV) vaccine, which has transformed cervical cancer prevention ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical ...